AVIR

AVIR EBITDA Margin

18.84%TTM

Period ending:

AVIR FY EBITDA Margin%
AVIR FY EBITDA Margin46.90%-30.09%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

AVIR ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Atea Pharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
0%
0%
0%
39.4513%
-22.641%
0%
0%

Compare ebitda margin

All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.